- Home
- AGO vs ZLAB Comparison
AGO vs ZLAB Comparison
Compare AGO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGO
- ZLAB
- Stock Information
- Founded
- AGO 2003
- ZLAB 2013
- Country
- AGO Bermuda
- ZLAB China
- Employees
- AGO 361
- ZLAB N/A
- Industry
- AGO Property-Casualty Insurers
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- AGO Finance
- ZLAB Health Care
- Exchange
- AGO Nasdaq
- ZLAB Nasdaq
- Market Cap
- AGO 4.3B
- ZLAB 3.6B
- IPO Year
- AGO 2004
- ZLAB 2017
- Fundamental
- Price
- AGO $85.50
- ZLAB $36.40
- Analyst Decision
- AGO Buy
- ZLAB Buy
- Analyst Count
- AGO 3
- ZLAB 5
- Target Price
- AGO $103.33
- ZLAB $54.28
- AVG Volume (30 Days)
- AGO 356.3K
- ZLAB 886.5K
- Earning Date
- AGO 08-06-2025
- ZLAB 08-05-2025
- Dividend Yield
- AGO 1.59%
- ZLAB N/A
- EPS Growth
- AGO N/A
- ZLAB N/A
- EPS
- AGO 8.34
- ZLAB N/A
- Revenue
- AGO $884,000,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- AGO N/A
- ZLAB $44.07
- Revenue Next Year
- AGO N/A
- ZLAB $49.13
- P/E Ratio
- AGO $10.25
- ZLAB N/A
- Revenue Growth
- AGO N/A
- ZLAB 43.72
- 52 Week Low
- AGO $72.57
- ZLAB $16.01
- 52 Week High
- AGO $96.50
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- AGO 48.55
- ZLAB 52.67
- Support Level
- AGO $84.76
- ZLAB $34.79
- Resistance Level
- AGO $88.01
- ZLAB $36.73
- Average True Range (ATR)
- AGO 1.48
- ZLAB 1.23
- MACD
- AGO 0.00
- ZLAB -0.46
- Stochastic Oscillator
- AGO 42.56
- ZLAB 25.91
About AGO Assured Guaranty Ltd.
Assured Guaranty Ltd. provides credit protection products to the United States and international public finance and structured finance markets and manages assets across collateralized loan obligations as well as opportunity funds and liquid funds that build on its corporate credit, asset-based finance, municipal, and healthcare experience. The company operates in two segments: the Insurance segment and the Asset Management segment. The majority of the revenue earned by the company is from the Insurance segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.